**Core Concept**
The management of superficial bladder cancer involves various intravesical therapies aimed at eradicating tumor cells within the bladder. Intravesical therapy refers to the direct instillation of medication into the bladder to treat conditions such as bladder cancer.

**Why the Correct Answer is Right**
Mitomycin C is a chemotherapy agent that works by inhibiting DNA synthesis and function, leading to cell death. When administered intravesically, Mitomycin C is effective in treating superficial bladder cancer by directly killing cancer cells in the bladder. Its mechanism of action involves the inhibition of ribonucleotide reductase, an enzyme necessary for DNA synthesis. This leads to the accumulation of DNA damage and subsequent cell death, making Mitomycin C an effective treatment option for superficial bladder cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** BCG (Bacillus Calmette-Guérin) is a live, attenuated Mycobacterium bovis strain used as an intravesical immunotherapy for superficial bladder cancer. While effective, BCG works by inducing a local immune response against cancer cells, rather than directly killing them like Mitomycin C.

**Option B:** Doxorubicin is a chemotherapeutic agent that works by intercalating DNA and inhibiting topoisomerase II, leading to cell death. However, its use as an intravesical therapy for superficial bladder cancer is less effective compared to Mitomycin C due to its higher systemic toxicity and lower local concentration within the bladder.

**Option C:** Valrubicin is a chemotherapeutic agent that works by intercalating DNA and inhibiting topoisomerase II, leading to cell death. While used as an intravesical therapy for superficial bladder cancer, its efficacy is lower compared to Mitomycin C, and it has a higher risk of systemic toxicity.

**Clinical Pearl / High-Yield Fact**
Intravesical therapy for superficial bladder cancer should be administered under sterile conditions to minimize the risk of infection and ensure optimal efficacy. A minimum of 6-8 weeks of treatment is recommended to allow for maximum response.

**Correct Answer:** C. Valrubicin